Gen-Probe Deal to Acquire Tepnel Expected to be Effective in April | GenomeWeb

NEW YORK (GenomeWeb News) – Tepnel Life Sciences today said that Gen-Probe's offer to acquire the firm for £92.8 million ($132.1 million) is expected to become effective on or around April 8.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.